BRITTANY ARBACHESKI FAIS: Open Payments
NPI 1326607276 · GULF BREEZE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 23 payments from 13 companies in 2025. Trend: 2023 $439 · 2024 $366 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| ABBVIE INC. | 2 | $51 |
| Amgen Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Corium, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: AIRSUPRA, EVENITY, TRINTELLIX, REXULTI, SHINGRIX, QULIPTA, Azstarys, Symbravo.
Industry payments across FL — which companies pay providers there.
